US generics players Bayshore Pharmaceuticals and Unichem Pharmaceuticals USA could soon be combined into a single US generic formulations player, under plans unveiled by Bayshore owner and Unichem majority shareholder Ipca Laboratories.
Ipca and Unichem both announced via BSE filings today that a meeting of the board of directors would be held...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?